XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$1.91
-0.01 (-0.52%)
Open$1.97
Previous Close$1.92
Day High$2.09
Day Low$1.85
52W High$9.85
52W Low$2.42
Volume—
Avg Volume480
Market Cap5.87M
P/E Ratio—
EPS$-2.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+2,132.5% upside
Current
$1.91
$1.91
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.67M | 113.60M | 1.25M |
| Net Income | -8,576,589 | -9,671,632 | 338.7K |
| Profit Margin | -2.6% | -2.5% | 27.0% |
| EBITDA | -10,156,648 | -12,089,732 | 499.5K |
| Free Cash Flow | — | — | 161.5K |
| Rev Growth | -20.2% | -20.2% | +20.7% |
| Debt/Equity | 0.02 | 0.02 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |